Oral administration of Bifidobacterium breve B-3 modifies metabolic functions in adults with obese tendencies in a randomised controlled trial

Accumulating evidence suggests an association between gut microbiota and the development of obesity, raising the possibility of probiotic administration as a therapeutic approach. Bifidobacterium breve B-3 was found to exhibit an anti-obesity effect on high-fat diet-induced obesity mice. In the pres...

Descripción completa

Detalles Bibliográficos
Autores principales: Minami, Jun-ichi, Kondo, Shizuki, Yanagisawa, Naotake, Odamaki, Toshitaka, Xiao, Jin-zhong, Abe, Fumiaki, Nakajima, Shigeru, Hamamoto, Yukie, Saitoh, Sanae, Shimoda, Taeko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4463018/
https://www.ncbi.nlm.nih.gov/pubmed/26090097
http://dx.doi.org/10.1017/jns.2015.5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4463018/
https://www.ncbi.nlm.nih.gov/pubmed/26090097
http://dx.doi.org/10.1017/jns.2015.5

Ejemplares similares